Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Alzheimer's Disease

Free Subscription 16.11.2026 4 Alzheimers Dement 1 BMC Geriatr 2 Brain 4 Curr Alzheimer Res 4 Exp Neurol 4 J Alzheimers Dis 1 J Neurosci 1 Lancet Neurol 1 Nat Rev Neurosci 1 Nature 1 Neurol Genet 3 Neurology 2 Neuroscience 1 Science

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Alzheimers Dement

1. KIM JS, Han SS, Yoo SH, Lee DH, et al
   AI-Integrated multimodal neuroimaging in Alzheimer's disease: toward biologically informed precision diagnostics.
   Alzheimers Dement. 2026;22:e71923.
   PubMed         Abstract available
   
   
2. BEY GS, Emrani S, Kulick ER, Roman CAF, et al
   Lifestyle interventions on Alzheimer's disease and related dementias: Social and structural determinants of implementation effectiveness and sustainability.
   Alzheimers Dement. 2026;22:e71957.
   PubMed         Abstract available
   
   
3. WU M, Luan Y, Xu X, Mao X, et al
   Diabetes mellitus is associated with altered Alzheimer's disease pathology.
   Alzheimers Dement. 2026;22:e72002.
   PubMed         Abstract available
   
   
4. XIE Z, Yang Q, Liu L, Chu M, et al
   Targeting peripheral cathepsin E restricts CD8(+) T-cell neuroinvasion and ameliorates Alzheimer's disease pathology.
   Alzheimers Dement. 2026;22:e71994.
   PubMed         Abstract available
   
   

   
   BMC Geriatr

5. LIU X, Guo Z, Fu B, Jia X, et al
   An impaired excitatory-inhibitory balance in the right inferior temporal gyrus of patients with Alzheimer's disease correlated with executive function.
   BMC Geriatr. 2026;26:1411.
   PubMed         Abstract available
   
   

   
   Brain

6. WILLIAMS DM, Mukadam N, Davies NM, Anderson EL, et al
   Understanding apolipoprotein E as a predominant cause of Alzheimer's disease.
   Brain. 2026 Nov 11:awag395. doi: 10.1093.
   PubMed         Abstract available
   
   
7. LEES AJ
   Love in the time of Alzheimer: Gabriel Garcia Marquez's pact with solitude.
   Brain. 2026 Nov 12:awag402. doi: 10.1093.
   PubMed        
   
   

   
   Curr Alzheimer Res

8. JIANG P, Guo X, Wang L, Huang W, et al
   Under-recognized Autoimmune Encephalitis in Patients with Alzheimer's Disease: A Case Series Emphasizing EEG Screening.
   Curr Alzheimer Res. 2026 Nov 4. doi: 10.2174/0115672050509968261027101230.
   PubMed         Abstract available
   
   
9. AKTER H, Siddique MAB, Tufael, Debnath A, et al
   Impact of Nursing Interventions on Cognitive Decline and Quality of Life in Alzheimer's Disease: A Comprehensive Mini-Review.
   Curr Alzheimer Res. 2026 Nov 4. doi: 10.2174/0115672050514304261027040607.
   PubMed         Abstract available
   
   
10. HENDERSON H, Crain N, Xie JY
    Which Modality of Physical Exercise is More Effective at Treating and Preventing Alzheimer's Disease: Aerobic or Anaerobic?
    Curr Alzheimer Res. 2026 Nov 5. doi: 10.2174/0115672050510461261027055519.
    PubMed         Abstract available
    
    
11. ZHANG H, Li X, Yang M, Chu B, et al
    Neuroinflammation and Brain Network Remodeling in Alzheimer's Disease: Integrating DTI, fMRI, TSPO-PET, and Fluid Biomarkers.
    Curr Alzheimer Res. 2026 Nov 10. doi: 10.2174/0115672050507382261028073350.
    PubMed         Abstract available
    
    

    
    Exp Neurol

12. CHENG W, Ma Y, Gao F, Shi Z, et al
    Effects of cranial X-ray irradiation in Presymptomatic 3 x Tg-AD mice.
    Exp Neurol. 2026;395:115482.
    PubMed         Abstract available
    
    
13. TUO C, Sui X, Cui C, Han F, et al
    Pramipexole improves cognitive deficits and synaptic plasticity impairments in 3xTg-AD mice through enhancing autophagy.
    Exp Neurol. 2026;395:115503.
    PubMed         Abstract available
    
    
14. DAHLEN AD, Roshanbin S, Bucher NM, Sehlin D, et al
    Evaluating the impact of age and treatment on neuroinflammation-related proteins in mouse models of proteinopathies.
    Exp Neurol. 2026;395:115475.
    PubMed         Abstract available
    
    
15. SU H, Wu F, Haque K, Zou S, et al
    5xFAD mutations induce hearing impairment in the Ahl-corrected 5xFAD mice.
    Exp Neurol. 2026;395:115463.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

16. TAKAHASHI R, Kashibayashi T, Fujita J, Yoshida K, et al
    Lower baseline cerebrospinal fluid amyloid-beta 42 is associated with amyloid-related imaging abnormalities during real-world lecanemab treatment.
    J Alzheimers Dis. 2026;114:627-631.
    PubMed         Abstract available
    
    
17. XING R, Sun W, Zhou J, Chen T, et al
    Quantitative analysis of intersecting pentagon drawings for interpretable cognitive impairment screening.
    J Alzheimers Dis. 2026;114:772-782.
    PubMed         Abstract available
    
    
18. LIANG EX, Li QW, Liang H
    Chinese herbal medicine formulas for Alzheimer's disease: Evidence, mechanisms, and translational standards.
    J Alzheimers Dis. 2026 Nov 10:13872877261505070. doi: 10.1177/13872877261505070.
    PubMed         Abstract available
    
    
19. DAJANI I, Alsheik N, Chaari A
    Multimodal neuroimaging in Alzheimer's disease: A practical, case-illustrated review of quantitative MRI and molecular PET.
    J Alzheimers Dis. 2026 Nov 13:13872877261505047. doi: 10.1177/13872877261505047.
    PubMed         Abstract available
    
    

    
    J Neurosci

20. RIVERA-RAMIREZ N, O'Malley JJ, Jagirdar R, Campbell JR, et al
    Thalamic Reticular Nucleus Excitability and Cholinergic Signaling are Disrupted in a Mouse Model of Alzheimer's Disease Neuropathology.
    J Neurosci. 2026 Nov 11:e1320262026. doi: 10.1523/JNEUROSCI.1320-26.2026.
    PubMed         Abstract available
    
    

    
    Lancet Neurol

21. BARTON ME, Byrnes W, van den Steen B, van Tricht H, et al
    Safety, tolerability, and efficacy of bepranemab in people living with prodromal-to-mild Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 2 trial.
    Lancet Neurol. 2026 Nov 10:S1474-4422(26)00357.
    PubMed         Abstract available
    
    

    
    Nat Rev Neurosci

22. EMERSON N, Vallejo K, Rahimzadeh N, Kwang NE, et al
    Single-cell and spatial transcriptomics of cellular heterogeneity in Alzheimer disease.
    Nat Rev Neurosci. 2026 Nov 6. doi: 10.1038/s41583-026-01096.
    PubMed         Abstract available
    
    

    
    Nature

23. BASU M
    New culprit in early Alzheimer's: blood-brain barrier blocks protective proteins.
    Nature. 2026 Nov 11. doi: 10.1038/d41586-026-03655.
    PubMed        
    
    

    
    Neurol Genet

24. KAUFMAN EJ, Smukowski SN, Gudsnuk K, Course MM, et al
    Alzheimer Disease Risk Variants at ABCA7 Tag Tandem Repeat Length.
    Neurol Genet. 2026;12:e200456.
    PubMed         Abstract available
    
    

    
    Neurology

25. OLIVEIRA TG
    Cerebral Amyloid Angiopathy Brain MRI Boston Criteria v2.0: Are We Ready to Implement Them in the Study of Patients With Alzheimer Disease?
    Neurology. 2026;107:e218815.
    PubMed        
    
    
26. LALIVE HM, Ribaldi F, Mendes AJ, Wang C, et al
    Cerebral Amyloid Angiopathy in Alzheimer Disease Continuum: Prevalence and Clinical Relevance in a Biomarker-Defined Memory Clinic Cohort.
    Neurology. 2026;107:e218738.
    PubMed         Abstract available
    
    
27. LORKIEWICZ SA, Abdelnour C, Bolen ML, Smith AM, et al
    Plasma P-Tau217 as a Prognostic, Monitoring, and Risk-Stratification Biomarker of Clinical Progression in Lewy Body Disease.
    Neurology. 2026;107:e218686.
    PubMed         Abstract available
    
    

    
    Neuroscience

28. LIU Y, Tian K, Jiao K, Wu N, et al
    Amyloid-beta dimers bind to microglial TLR2 to induce early neuroinflammation and cognitive deficits in Alzheimer's disease.
    Neuroscience. 2026 Nov 10:S0306-4522(26)00739.
    PubMed         Abstract available
    
    
29. SHARMA C, Basak M, Dhungel A, Hazam PK, et al
    From insulin resistance to neurovascular breakdown: mTOR signaling as a convergence point in Alzheimer's disease.
    Neuroscience. 2026 Nov 11:S0306-4522(26)00740.
    PubMed         Abstract available
    
    

    
    Science

30. SMITH JE
    The sideshow.
    Science. 2026;394:712-715.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum